Bristol Myers buys Nvidia SuperPOD — can it actually speed up drug discovery?

bristol myers squibb is deploying an nvidia dgx superpod powered by the vera rubin architecture. the system aims to streamline artificial intelligence across its drug discovery and development workflows. it marks the first deployment of this architecture in the life sciences sector. this signals a shift from experimental ai tools to essential infrastructure for competitive biotech research.